Literature DB >> 21658611

Pathology, pathogenesis and molecular genetics of follicular NHL.

E Leich1, G Ott, A Rosenwald.   

Abstract

Follicular lymphoma (FL) is a germinal centre-derived indolent B-cell lymphoma representing the second most common Non Hodgkin lymphoma in the Western world. This chapter focuses on the pathology of FL and summarizes the current knowledge about genetic and molecular features that are relevant for the pathogenesis of this neoplasm. The translocation t(14;18) is present in approximately 90% of FL leading to the upregulation of the anti-apoptotic protein BCL2, that may constitute a promising molecular target for therapeutic approaches. FL lacking the t(14;18) also exist, and B-cells carrying the t(14;18) can be detected in a subset of healthy individuals. In addition to the t(14;18), secondary genetic alterations are present in most FL and, more recently, deeper insights into the methylation and microRNA expression patterns in the tumour cells have been gained. The tumour microenvironment appears to be particularly important for the biology and the clinical course of FL.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658611     DOI: 10.1016/j.beha.2011.02.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  12 in total

Review 1.  Nonsense-mediated mRNA decay: The challenge of telling right from wrong in a complex transcriptome.

Authors:  Aparna Kishor; Sarah E Fritz; J Robert Hogg
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-05-26       Impact factor: 9.957

2.  hnRNP L-dependent protection of normal mRNAs from NMD subverts quality control in B cell lymphoma.

Authors:  Aparna Kishor; Zhiyun Ge; J Robert Hogg
Journal:  EMBO J       Date:  2018-12-07       Impact factor: 11.598

3.  Assessing the prognostic impact of immune cell infiltrates in follicular lymphoma.

Authors:  Falko Fend; Leticia Quintanilla-Martínez
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

4.  Activating STAT6 mutations in follicular lymphoma.

Authors:  Mehmet Yildiz; Hongxiu Li; Denzil Bernard; Nisar A Amin; Peter Ouillette; Siân Jones; Kamlai Saiya-Cork; Brian Parkin; Kathryn Jacobi; Kerby Shedden; Shaomeng Wang; Alfred E Chang; Mark S Kaminski; Sami N Malek
Journal:  Blood       Date:  2014-11-26       Impact factor: 22.113

5.  Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma.

Authors:  Olivia I Koues; Rodney A Kowalewski; Li-Wei Chang; Sarah C Pyfrom; Jennifer A Schmidt; Hong Luo; Luis E Sandoval; Tyler B Hughes; Jeffrey J Bednarski; Amanda F Cashen; Jacqueline E Payton; Eugene M Oltz
Journal:  Immunity       Date:  2014-12-25       Impact factor: 31.745

6.  Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.

Authors:  Hongxiu Li; Mark S Kaminski; Yifeng Li; Mehmet Yildiz; Peter Ouillette; Siân Jones; Heather Fox; Kathryn Jacobi; Kamlai Saiya-Cork; Dale Bixby; Daniel Lebovic; Diane Roulston; Kerby Shedden; Michael Sabel; Lawrence Marentette; Vincent Cimmino; Alfred E Chang; Sami N Malek
Journal:  Blood       Date:  2014-01-16       Impact factor: 22.113

7.  The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium.

Authors:  Birgitta Sander; Daphne de Jong; Andreas Rosenwald; Wanling Xie; Olga Balagué; Maria Calaminici; Joaquim Carreras; Philippe Gaulard; John Gribben; Anton Hagenbeek; Marie José Kersten; Thierry Jo Molina; Abigail Lee; Santiago Montes-Moreno; German Ott; John Raemaekers; Gilles Salles; Laurie Sehn; Christoph Thorns; Björn E Wahlin; Randy D Gascoyne; Edie Weller
Journal:  Haematologica       Date:  2014-02-07       Impact factor: 9.941

Review 8.  The status of radioimmunotherapy in CD20+ non-Hodgkin's lymphoma.

Authors:  Evan D Read; Peter Eu; Peter J Little; Terrence J Piva
Journal:  Target Oncol       Date:  2014-05-29       Impact factor: 4.493

9.  Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma.

Authors:  Zhang Xiao Ying; Meiyan Jin; Luke F Peterson; Denzil Bernard; Kamlai Saiya-Cork; Mehmet Yildiz; Shaomeng Wang; Mark S Kaminski; Alfred E Chang; Daniel J Klionsky; Sami N Malek
Journal:  Clin Cancer Res       Date:  2016-06-07       Impact factor: 12.531

10.  Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma.

Authors:  A Barreca; C Martinengo; L Annaratone; L Righi; A Chiappella; M Ladetto; A Demurtas; L Chiusa; A Stacchini; N Crosetto; A van Oudenaarden; R Chiarle
Journal:  Blood Cancer J       Date:  2014-10-10       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.